Tags: Drug.
Ezetimibe/atorvastatin (brand name Liptruzet) is a cholesterol lowering combination drug. In the United States it was approved in May 2013 by the Food and Drug Administration for the treatment of elevated low-density lipoprotein (LDL) in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet.Some cardiologists opposed the approval because the combination reduced LDL cholesterol in a clinical trial it did not reduce heart disease.